DVA - DaVita Inc.

NYSE - NYSE Delayed price. Currency in USD
59.35
+0.65 (+1.11%)
At close: 4:02PM EDT
Stock chart is not supported by your current browser
Previous close58.70
Open58.99
Bid0.00 x 0
Ask0.00 x 0
Day's range58.99 - 59.97
52-week range53.58 - 70.16
Volume2,576,555
Avg. volume1,907,448
Market cap11.35B
Beta1.05
PE ratio (TTM)9.04
EPS (TTM)N/A
Earnings dateN/A
Forward Dividend & YieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
Trade prices are not sourced from all markets
  • Market Realist4 days ago

    DaVita Healthcare Partners: S&P 500’s Top Gainer on October 16

    DaVita Healthcare Partners, one of the largest kidney care companies in the US, was the S&P 500's top gainer on October 16, 2017.

  • The Wall Street Journal5 days ago

    [$$] These Companies Will Pay You to Learn Your Job

    A handful of companies are using so-called last-mile programs to train new hires for as long as a year before taking them on as full-time members of the team.

  • Barrons.com6 days ago

    The Hot Stock: DaVita Surges

    Shares of DaVita (DVA) climbed to the top of th S&P 500 index Monday after the dialysis clinic operator revealed additional information regarding the profit its derives from patients subsidized by American Kidney Fund Charity. DaVita gained more than 4% to end the day at $56.93 a share, while the S&P 500 inched 0.18% higher today. For months, DaVita’s stock has been weighed down by questions about the American Kidney Fund, the portion of the company’s revenue dependent the charity and the huge premiums it gets paid for some services.

  • 3 Growth Stocks at Value Stock Prices
    Motley Fool9 days ago

    3 Growth Stocks at Value Stock Prices

    DaVita, Tellurain, and Skechers look like intriguing value stocks in today's market.

  • 3 Healthcare Value Stocks
    Motley Fool9 days ago

    3 Healthcare Value Stocks

    Looking for some investments in the healthcare sector that aren't priced at a high premium? Allergan, Gilead Sciences, and DaVita are an excellent place to start.

  • Barrons.com13 days ago

    The Biggest Loser: DaVita Tumbles 9.9%

    DaVita (DVA) tumbled to the bottom of the S&P 500 today after getting cut to Underweight from Neutral at JPMorgan. DaVita dropped 9.9% to $53.89 today, while the S&P 500 declined 0.2% to 2544.73. JPMorgan's Gary ...

  • Barrons.com13 days ago

    JP Morgan: Hasta DaVita!

    J.P. Morgan says it’s time sell DaVita (DVA). The firm downgraded the chain of dialysis clinics to Underweight and cut his price target from $66 a share to $51 a share. According to theflyonthewall, updated disclosures from the American Kidney Fund added to concerns regarding how much of the company’s earnings is derived from the controversial organization.

  • Barrons.com13 days ago

    Morning Sector Snapshot: Oilfield Services Rise; Healthcare Slips

    National Oilwell Varco (NOV) helped oilfield services to the top spot. Sempre (SRE) and NiSource (NI) are boosting gas distributors. Computer peripherals are up, helped by Seagate (STX). DaVita (DVA) is ...

  • DaVita Banks on Acquisitions, Escalating Expenses a Concern
    Zacks13 days ago

    DaVita Banks on Acquisitions, Escalating Expenses a Concern

    DaVita HealthCare Partners' (DVA) focus on acquisitions will boost the company's expansion. However, rising expenses remains headwind.

  • CNBC2 months ago

    Cramer's lightning round: Don't sell this tobacco stock despite the new restrictions

    Jim Cramer rattles off his take on callers' favorite stocks, including tobacco product giant Philip Morris International.

  • Court throws out last-minute Obama rule: Dialysis providers won't have to disclose aid to patients
    CNBC9 months ago

    Court throws out last-minute Obama rule: Dialysis providers won't have to disclose aid to patients

    Health regulators warned that third-party financial help for insurance premiums to patients could drive up health costs and hurt insurers bottom lines.

  • CNBC9 months ago

    Dialysis providers win victory in fight over third-party financial aid to patients

    Federal health regulators are concerned that dialysis patients are being steered into private insurance as opposed to Medicare or Medicaid.

  • Reuters - UK Focus9 months ago

    European shares slip as bank losses offset tech gains; FTSE hits new high

    European shares slipped on Monday as a pullback in bank stocks more than offset a stronger tech sector, while a drop in the pound drove Britain's FTSE 100 index to further record highs. The pan-European STOXX index slid 0.4 percent, while the FTSE 100 rose 0.4 percent after hitting an all-time high of 7,243.76 points in its 10th straight session of gains. The pound sank to more than two-month lows after weekend comments from British Prime Minister Theresa May sparked talk that Britain would drastically rework trade relations with the European Union after Brexit.

  • Reuters - UK Focus9 months ago

    European shares slip, Britain's FTSE 100 at record high

    European shares edged lower on Monday, while a rise among basic resources stocks helped Britain's FTSE 100 index hit a record high. The FTSE 100 gained 0.3 percent to 7,239.26 points, putting it on track for its tenth straight session of gains. "I think the appetite is there to keep (the FTSE) pushing north.

  • DaVita shares jump on change for Medicaid patients seeking ACA coverage
    CNBClast year

    DaVita shares jump on change for Medicaid patients seeking ACA coverage

    DaVita will suspend support for applications to the AKF for charitable premium assistance by patients enrolled in minimum essential Medicaid coverage.

By using Yahoo you agree that Yahoo and partners may use Cookies for personalisation and other purposes